Last updated: September 14, 2025
Introduction
Patent RU2014141700, granted by the Russian Federation, pertains to a specific pharmaceutical invention. Understanding its scope, claims, and position within the patent landscape is vital for stakeholders such as generic pharma companies, patent attorneys, and strategic R&D teams. This analysis systematically dissects the patent's claims, evaluates its patentability, and explores the broader landscape context within Russia's intellectual property framework.
Patent Overview and Basic Data
- Patent Number: RU2014141700
- Filing Date: August 20, 2014
- Grant Date: October 21, 2015
- Priority Date: August 20, 2013 (based on the initial application, if applicable)
- Patent Term: 20 years from filing, subject to maintenance and annuities.
- Publication: Official Gazette of Rospatent, accessible for detailed claims.
This patent relates to a pharmaceutical composition, compound, or method—typically defined within its claims section—aimed at treating or diagnosing a particular medical condition or offering improved efficacy, stability, or delivery.
Scope and Claims Analysis
Type of Claims
RU patents generally comprise:
- Independent Claims: Broad claims defining the core of the invention, specifying novel compounds, compositions, or processes.
- Dependent Claims: Narrower claims refining or including specific embodiments, concentrations, or formulations.
Given the typical style, RU2014141700 likely includes:
- Compound Claims: Covering a chemical entity or class thereof.
- Use Claims: Methods of treatment or diagnosis.
- Formulation Claims: Specific compositions or delivery mechanisms.
Scope of the Claims
-
Compound Claims:
The patent might cover a specific chemical compound or a class characterized by a certain core structure and substituents. The claims probably specify parameters such as molecular weight, chemical groups, or isomeric configurations, providing a broad but precise scope intended to prevent easy design-around.
-
Use Claims:
The patent may claim the application of the compound or composition for treating a particular disease or condition. Such claims enhance commercial value by covering therapeutic or diagnostic uses, potentially even extending protection into new indications if appropriately drafted.
-
Formulation and Delivery Claims:
These may involve specific formulations that improve bioavailability, stability, or targeted delivery, adding further layers of protection.
Claim Scope Limitations
- The scope's breadth is constrained by the novelty and inventive step criteria.
- The claims likely avoid overly broad language that would invite invalidity objections, instead focusing on defining the compound or method with specific structural or process features.
Note: Exact claim language would be essential for detailed legal interpretation, but general principles indicate a combination of compound, use, and formulation claims designed for comprehensive protection.
Patentability and Validity Considerations
In Russia, patentability hinges on novelty, inventive step, and industrial applicability. The claims' scope aligns with these principles:
-
Novelty:
Claims must differ significantly from prior art, including earlier Russian and international patents, publications, or scientific disclosures. For pharmaceutical patents, this often involves unique chemical modifications or unexpected therapeutic effects.
-
Inventive Step:
The claims demonstrate inventive activity if the claimed compounds or methods are not obvious to someone skilled in the art, especially considering prior art references.
-
Industrial Applicability:
The patent covers practical, repeatable uses within medical or manufacturing contexts.
The patent prosecution process likely included prior art searches and office actions addressing any objections concerning claim clarity, scope, or inventive level.
Patent Landscape for Similar Obviousness or Competing Patents in Russia
1. Prior Art and Similar Patents
Within Russia’s patent landscape, numerous patents relate to pharmacologically active compounds, especially in areas such as:
- Anticancer agents
- Antiviral drugs
- Cardiovascular medicinals
- Novel delivery systems
A comprehensive patent landscape analysis would involve:
- Search of the Federal Institute's database (Rospatent) for similar chemical structures or therapeutic methods
- Cross-referencing with international applications filed via PCT or direct filings in Russia
Key observation: Russian patent applications often build upon European or US-origin inventions, especially in chemical classes like heterocyclic compounds, indicating potential overlaps or cumulative rights.
2. Patent Families and Related Applications
The applicant may hold related patent family members in territories such as Europe (EPO), the US (USPTO), or other jurisdictions, strengthening global patent position and influencing the Russian patent’s strategic value.
3. Patent Term and Limitations
The competition must monitor any opposed or invalidated patents, especially those with overlapping claims, as patent rights in Russia are susceptible to challenge via mechanisms like pre-grant or post-grant oppositions.
Legal and Commercial Significance
- The scope of RU2014141700 appears calibrated for broad protection, with potential claims covering multiple embodiments.
- Its relative temporal position, filed in 2014 with patent life until 2034, positions it well within the biotech patent life cycle, pending maintenance.
- The patent's enforceability depends on thorough clearance searches and monitoring of potential infringers, particularly in the context of generic development.
Conclusion & Strategic Implications
The scope and claims of RU2014141700 reflect a standard approach to pharmaceutical patents: balancing broad, enforceable protections with specificity to withstand legal challenges. For innovators, it offers a substantial barrier against generics within Russia, especially if it covers unique compounds or uses.
The patent landscape indicates dynamic competition in the pharmaceutical space, with overlapping rights necessitating vigilant freedom-to-operate analyses. Stakeholders should consider potential licensing, cross-licensing, or strategic patent filings to strengthen market position.
Key Takeaways
- Scope of RU2014141700 encompasses specific chemical compounds, uses, and formulations designed for therapeutic application, with claims structured to maximize broad protection.
- Claims strategy balances broad coverage with sufficient specificity to meet patentability standards, providing a robust legal toolkit against infringement.
- Patent landscape analysis reveals active innovation in Russia around pharmaceutical compounds, with overlapping rights requiring ongoing monitoring.
- Strategic advantage is derived from leveraging broad claims, patent family extensions, and vigilant enforcement to sustain market exclusivity.
- Future actions should include continuous prior art surveillance, potential patent family expansion, and readiness for opposition or litigation if challenged.
FAQs
1. How broad are the claims of RU2014141700?
The claims likely cover specific chemical compounds and their therapeutic uses, with dependent claims narrowing the scope via particular structural features or formulations. This balance aims to ensure broad protection while maintaining validity.
2. Can this patent block generic competitors in Russia?
Yes, if successfully enforced, it provides exclusive rights within Russia for the protected compounds or uses, preventing generic manufacture or sale without licensing.
3. How does RU2014141700 compare with similar international patents?
It potentially aligns with or derives from prior art in international patents, especially if applicants pursue global patent family coverage; however, local validation and validation strategies are critical.
4. What strategies can companies adopt to work around this patent?
Designing compounds outside the scope of the claims or developing alternative formulations or methods not covered by the patent claims may circumvent rights legally.
5. What are the main challenges in maintaining this patent’s validity?
Challenges include overcoming prior art rejections, defending against invalidation attempts, and monitoring for patent term or procedural lapses.
References
[1] Rospatent official database. Patent RU2014141700.
[2] Russian Patent Law, Federal Law No. 63-FZ of July 31, 2001.
[3] WIPO PATENTSCOPE and Espacenet patent search tools.
[4] EPO Guidelines for Examination, Part G, Chapter 3.
[5] Russian Pharmaceutical Patent Standards and Guidelines.
Note: For precision, a detailed review of the full claim set and specification is advised. This report provides a high-level, strategic overview based on available information and typical patent practices in the Russian pharmaceutical sector.
